A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2011

Conditions
Essential Hypertension
Interventions
DRUG

Fimasartan/HCTZ combination

Fimasartan/HCTZ combination 60/12.5mg 120/12.5mg

DRUG

Fimasartan

Fimasartan 60mg, 120mg

Trial Locations (1)

Unknown

Seoul National University Hospital, Bundang, Sungnam

Sponsors
All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Korea University Guro Hospital

OTHER

collaborator

DongGuk University

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Gangnam Severance Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Ajou University

OTHER

collaborator

Chonbuk National University Hospital

OTHER

collaborator

Cheil General Hospital and Women's Healthcare Center

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Hanyang University

OTHER

collaborator

Yonsei University

OTHER

collaborator

Ilsan-Paik Hospital

UNKNOWN

collaborator

SMG-SNU Boramae Medical Center

OTHER

collaborator

Kyung Hee University Hospital

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY